Outline of Clinical Trials on Cancer

Topic outline

• 

  General

  • Certificate issue 修了証発行

    Restricted Not available unless:

    • The activity questionnaire_01 is marked complete
    • The activity questionnaire_02 is marked complete
    • The activity questionnaire_03 is marked complete
    • The activity questionnaire_04 is marked complete
    • The activity questionnaire_05 is marked complete
    • The activity questionnaire_06 is marked complete
• 

  Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2

  Some key points for interpreting the results of phase III randomized controlled trials are introduced in this lecture. Particularly, this part outlines survival curve and randomization.
  

  • lecture_01 SCORM package
  • questionnaire_01 Feedback

    Restricted Not available unless: The activity lecture_01 is marked complete
  • Document download_01 File 522.4KB PDF document
  • capture.png File 45.1KB Image (PNG)
  • 0:18:37
    

• 

  Minimum statistical knowledge required for clinical trials on cancer - Part 2 of 2

  Some key points for interpreting the results of phase III randomized controlled trials are introduced in this lecture. Particularly, this part outlines verification and evaluation of results, and ITT analysis set.
  

  • lecture_02 SCORM package
  • questionnaire_02 Feedback

    Restricted Not available unless: The activity lecture_02 is marked complete
  • Document download_02 File 765.3KB PDF document
  • capture.png File 46.6KB Image (PNG)
  • 0:25:21
    

• 

  Designs for clinical trials on cancer - Part 1 of 2

  Development flow and clinical trial designs of anticancer drugs are introduced in this lecture. Particularly, this part outlines development flow and phase I clinical trial designs.
  

  • lecture_03 SCORM package
  • questionnaire_03 Feedback

    Restricted Not available unless: The activity lecture_03 is marked complete
  • Document download_03 File 536.4KB PDF document
  • capture.png File 35.4KB Image (PNG)
  • 0:31:42
    

• 

  Designs for clinical trials on cancer - Part 2 of 2

  Development flow and clinical trial designs of anticancer drugs are introduced in this lecture. Particularly, this part outlines phase II and III clinical trial designs.
  

  • lecture_04 SCORM package
  • questionnaire_04 Feedback

    Restricted Not available unless: The activity lecture_04 is marked complete
  • Document download_04 File 630.8KB PDF document
  • capture.png File 35.2KB Image (PNG)
  • 0:24:56
    

• 

  Response evaluation and adverse events - Part 1 of 2

  Methods for response evaluation and adverse event reporting used in clinical trials on cancer are introduced in this lecture. Particularly, this part outlines response evaluation.
  

  • lecture_05 SCORM package
  • questionnaire_05 Feedback

    Restricted Not available unless: The activity lecture_05 is marked complete
  • Document download_05 File 1.2MB PDF document
  • capture.png File 34.2KB Image (PNG)
  • 0:27:58
    

• 

  Response evaluation and adverse events - Part 2 of 2

  Methods for response evaluation and adverse event reporting used in clinical trials on cancer are introduced in this lecture. Particularly, this part outlines adverse event reporting.
  

  • lecture_06 SCORM package
  • questionnaire_06 Feedback

    Restricted Not available unless: The activity lecture_06 is marked complete
  • Document download_06 File 683.5KB PDF document
  • capture.png File 34.9KB Image (PNG)
  • 0:21:48